1. Home
  2. TRAK vs HUMA Comparison

TRAK vs HUMA Comparison

Compare TRAK & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

HOLD

Current Price

$10.44

Market Cap

186.2M

Sector

Technology

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.30

Market Cap

155.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRAK
HUMA
Founded
1990
2004
Country
United States
United States
Employees
N/A
184
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.2M
155.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
TRAK
HUMA
Price
$10.44
$1.30
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$6.19
AVG Volume (30 Days)
101.7K
7.3M
Earning Date
05-14-2026
05-15-2026
Dividend Yield
0.90%
N/A
EPS Growth
20.69
N/A
EPS
0.28
N/A
Revenue
$21,007,076.00
N/A
Revenue This Year
$6.61
$444.16
Revenue Next Year
$10.04
$248.39
P/E Ratio
$36.82
N/A
Revenue Growth
4.84
N/A
52 Week Low
$6.94
$0.55
52 Week High
$22.17
$2.93

Technical Indicators

Market Signals
Indicator
TRAK
HUMA
Relative Strength Index (RSI) 62.93 68.49
Support Level $10.03 $0.89
Resistance Level $10.64 $1.72
Average True Range (ATR) 0.46 0.13
MACD 0.02 0.03
Stochastic Oscillator 83.33 92.45

Price Performance

Historical Comparison
TRAK
HUMA

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: